key: cord-0806762-1lcsolt2 authors: Türe, Esra; Korkmaz, Muhammet Furkan; Aksoy, Fatma Dilşad; Ceylan Demirbaş, Başak; Menekşe, Burcu; Çiftçi, Mehtap; Korkmaz, Merve title: Point‐of‐care lung ultrasound findings in the pediatric emergency clinic during the COVID‐19 pandemic date: 2020-11-13 journal: J Clin Ultrasound DOI: 10.1002/jcu.22947 sha: 8fdfaac53043141704ed68d246e86c0460a77cef doc_id: 806762 cord_uid: 1lcsolt2 PURPOSE: To describe our experience concerning lung ultrasound (LUS) in the pediatric emergency clinic, and to investigate the diagnostic value of LUS in coronavirus disease‐2019 (COVID‐19). METHODS: Patients aged under 18 admitted to the pediatric emergency clinic with suspicion of COVID‐19, who underwent point‐of‐care LUS and from whom COVID‐19 reverse transcription polymerase chain reaction (RT‐PCR) samples were collected, were included in the study. RESULTS: Point‐of‐care LUS was performed on 74 patients in the emergency room. LUS findings were more sensitive than chest X‐ray in the early stages of the disease and in mild cases. Involvement was observed at LUS despite RT‐PCR being negative in some symptomatic patients with a COVID‐19 contact history. CONCLUSIONS: We think that LUS can be beneficial in terms of identifying patients with lung involvement and staging their severity in this new disease in pediatric emergency clinics. The procedure is noninvasive, rapid, reproducible, and low cost, involving simple sterilization. Based on the current literature and our own practical experience, we think that increased use of point‐of‐care LUS can protect patients from unnecessary radiation and treatment delays during the COVID‐19 pandemic. Patients with pneumonia caused by a new type of coronavirus infection appeared in Wuhan city in the Chinese province of Hubei in early December 2019, after which the disease spread rapidly and worldwide. 1 The World Health Organization named the disease caused by the new infection "coronavirus disease-2019" (COVID-19). 2 The clinical symptoms of COVID-19 can range from a mild, self-limiting flu-like syndrome, to acute respiratory distress syndrome (ARDS), and lifethreatening multiorgan failure, and interstitial pneumonia. 3 Numerous previous studies have shown that lung ultrasound (LUS) is capable of detecting interstitial lung disease and subpleural consolidations. [4] [5] [6] In addition, evidence from recent studies has confirmed the usefulness of LUS in the diagnosis, management, and follow-up of patients with COVID-19 pneumonia. [7] [8] [9] Although several studies have investigated LUS in adult patients with COVID-19, the literature for the pediatric age group is limited. The purpose of this study is to report our experiences concerning LUS in the pediatric emergency clinic, to investigate the diagnostic value of LUS in COVID-19, and to gather evidence and contribute urgently needed information by retrospectively examining the point-of-care LUS findings of patients with fever or cough admitted to our pediatric emergency clinic with suspected COVID-19. Patients aged under 18 admitted to the pediatric emergency clinic with suspected COVID-19 between March 15, 2020 and May 10, 2020, who underwent point-of-care LUS, and from whom COVID-19 reverse transcription polymerase chain reaction (RT-PCR) samples were collected, were included in the study. Patient data were retrieved from patient files and the hospital automation system. Age, sex, COVID-19 contact history, LUS findings, COVID-19 RT-PCR results, and chest X-ray (CXR) findings were recorded. Patients not undergoing RT-PCR or LUS, or with symptoms other than fever or cough were excluded from the study. Sonographic lung evaluations were performed by a single operator (pediatric emergency specialist) with 4 years' experience of point-of-care LUS using a LOGIQ P9 (GE Healthcare, Wauwatosa, Wisconsin) ultrasound (US) device. LUS was performed using personal protective equipment and with all requisite precautions being taken against infection transmission. The US device was disinfected after each patient. A low-frequency convex probe was used to evaluate lung parenchymal structures, and a high-frequency linear probe was used to evaluate the pleural line. LUS was performed with patients in the sitting or supine positions, depending on their age. If the patient was in the sitting position, 14 segments of both hemithoraces, including anterior (superior/inferior), lateral (superior/inferior), and posterior (superior/medial/inferior) segments were examined. If the patient was in the supine position, eight segments including anterior (superior/ inferior) and lateral (superior/inferior) segments were examined. LUS findings such as pleural thickening, pleural irregularity, subpleural consolidation, B lines, and white lung were recorded. Descriptive analyses were used to analyze the distribution and frequency of data, and the Chi-square test was used to compare two independent groups. The independent t test was used to compare mean values in two independent groups. Significance was set at <.05 for all statistical analyses. Table 1 . Although CXR has traditionally been used for the diagnosis of lung diseases, it may not be able to detect early-stage COVID-19 pneumonia. 17 RT-PCR has become the standard evaluation method for the diagnosis of COVID-19 infection according to current diagnostic criteria. 19 However, the rates of false-positive or false-negative results are still unclear. 20 Thoracic CT is often recommended as a screening tool for adult patients with suspected COVID-19 pneumonia. 21 We conclude that as a noninvasive, rapid, and reproducible procedure, also involving ease of sterilization and low costs, LUS can be useful in identifying patients with lung involvement and in staging their severity in this new disease in pediatric emergency clinics. Based on the current evidence concerning COVID-19 and our own practical experience, we think increased use of point-of-care LUS during the COVID-19 pandemic can protect patients from unnecessary exposure to radiation and treatment delays. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. ORCID Esra Türe https://orcid.org/0000-0002-1015-1764 Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia A review of coronavirus disease-2019 (COVID-19) Clinical characteristics of coronavirus disease 2019 in China Lung ultrasound for critically ill patients Thoracic ultrasonography: a narrative review Lung ultrasonography and vertical artifacts: the shape of air Chinese critical care ultrasound study group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic Is there a role for lung ultrasound during the COVID-19 pandemic? Lung ultrasound in Covid-19: a useful diagnostic tool The role of ultrasound lung artifacts in the diagnosis of respiratory diseases Point of care and intensive care lung ultrasound: A reference guide for practitioners during COVID-19 What's new in lung ultrasound during the COVID-19 pandemic International evidence-based recommendations for point-of-care lung ultrasound Sonographic signs and patterns of COVID-19 pneumonia Lung ultrasound in children with COVID-19: preliminary findings Lung ultrasound in children with COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Chest X-ray findings in 636 ambulatory patients with COVID-19 presenting to an urgent care center: a Normal chest X-ray is no guarantee Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT? Chest CT features of COVID-19 in Sensitivity of chest CT for COVID-19: comparison to RT-PCR Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases A preliminary study on the ultrasonic manifestations of peripulmonary lesions of non-critical novel coronavirus pneumonia (COVID-19 Can lung US help critical care clinicians in the early diagnosis of novel coronavirus (COVID-19) pneumonia? Point-of-care lung ultrasound findings in the pediatric emergency clinic during the COVID-19 pandemic